探测分子复杂性的深度:STAT3作为结肠直肠癌发病因子的关键架构师
Muhammad Suleman1,2, Safir Ullah Khan3, Shahid Ali2
1Laboratory of Animal Research Center (LARC), Qatar University, Doha, Qatar.
Current gene therapy
|October 30, 2024
概括
信号转换器和转录3激活器 (STAT3) 是结直肠癌 (CRC) 发展的关键因素. STAT3 抑制剂显示出治疗CRC治疗的治疗潜力,特别是那些向DNA结合域的抑制剂.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 结肠直肠癌 (CRC) 发病率正在上升,由于缺乏有效的治疗点,这带来了重大挑战.
- 信号转换器和转录3激活器 (STAT3) 是一个关键的细胞内转录因子,与CRC发育有关.
- 异常的STAT3激活促进CRC细胞的增殖,生存,血管新生,入侵和转移.
研究的目的:
- 审查CRC中关于STAT3的最新数据.
- 在CRC治疗中强调STAT3抑制剂的激活和功能.
- 突出STAT3作为CRC检测和治疗的有希望的目标.
主要方法:
- 对结直肠癌中STAT3信号研究的文献综述.
- 分析STAT3激活通路及其在CRC进展中的作用.
- 评估STAT3抑制剂的治疗潜力,特别是那些准DNA结合域 (DBD) 的治疗潜力.
主要成果:
- 在CRC组织中STAT3过度激活会增强瘤生长和转移.
- STAT3 抑制剂在临床前和临床环境中显示出治疗潜力.
- 针对STAT3DNA结合域 (DBD) 的抑制剂对CRC治疗特别有希望.
结论:
- STAT3是结直肠癌发展和进展的关键调解者.
- 准STAT3信号是一种可行的CRC治疗策略.
- 进一步研究STAT3抑制剂,特别是DBD向剂,是有效的CRC管理的必要条件.
相关概念视频
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K


